DGX
Quest Diagnostics, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$234.91
−0.04%Forward multiples
Based on analyst estimates
- P/E forward
- 20.05x
- P/E 2026E
- 20.98x
- P/E 2027E
- 19.51x
- P/E 2028E
- 17.97x
- P/S forward
- 2.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.62x
- PEG TTM
- 1.08x
- Price / book
- 3.45x
- Price / sales
- 2.24x
- Price / cash flow
- 14.62x
Enterprise value
- Enterprise value
- $32.0B
- EV / sales
- 2.77x
- EV / EBITDA
- 14.37x
- EV / EBIT
- 19.56x
- Market cap
- $25.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026